|
Volumn 31, Issue 3, 1992, Pages 187-192
|
Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract
a b c d d e f g |
Author keywords
[No Author keywords available]
|
Indexed keywords
NEDAPLATIN;
ADULT;
AGED;
ALOPECIA;
ANOREXIA;
ARTICLE;
BONE MARROW SUPPRESSION;
CONTROLLED STUDY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
NEPHROTOXICITY;
OTOTOXICITY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
TESTIS CANCER;
TRANSITIONAL CELL CARCINOMA;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, TRANSITIONAL CELL;
FEMALE;
HUMAN;
JAPAN;
MALE;
MIDDLE AGE;
NEOPLASMS, GERM CELL AND EMBRYONAL;
ORGANOPLATINUM COMPOUNDS;
PROSTATIC NEOPLASMS;
REMISSION INDUCTION;
TESTICULAR NEOPLASMS;
UROLOGIC NEOPLASMS;
|
EID: 0026453095
PISSN: 03445704
EISSN: 14320843
Source Type: Journal
DOI: 10.1007/BF00685546 Document Type: Article |
Times cited : (79)
|
References (15)
|